February 13, 2024 Comments Off on New patent for Ocuphire drug RYZUMVI Posted in: Patent Added Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…
February 13, 2024 Comments Off on New patent for Axsome Malta drug SUNOSI Posted in: Patent Added Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are twenty-three patents…
The post New patent for Axsome Malta drug SUNOSI appeared first on DrugP…